Luteolin inhibits <scp>FcεRΙ</scp> ‐ and <scp>MRGPRX2</scp> ‐mediated mast cell activation by regulating calcium signaling pathways-Reference-Cited by-同舟云学术

Luteolin inhibits FcεRΙ ‐ and MRGPRX2 ‐mediated mast cell activation by regulating calcium signaling pathways

Published:2022-03-21 Issue:5 Volume:36 Page:2197-2206
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Hao Yong¹²^ORCID,Che Delu¹,Yu Yanqin³,Liu Lixia⁴,Mi Shuhong⁵,Zhang Yang⁵,Hao Jinqi⁶,Li Wei⁵,Ji Musi²,Geng Songmei¹,Shi Jihai⁵

Affiliation:

1. Department of Dermatology, Northwest Hospital The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. Department of Dermatology, The Second Affiliated Hospital of Baotou Medical College Inner Mongolia University of Science and Technology Baotou China

3. Research Center of Clinical Epidemiology, The First Affiliated Hospital of Baotou Medical College Inner Mongolia University of Science and Technology Baotou China

4. Department of Dermatology Bayannur Hospital Bayannur China

5. Department of Dermatology, The First Affiliated Hospital of Baotou Medical College Inner Mongolia University of Science and Technology Baotou China

6. School of Public Health, Baotou Medical College Inner Mongolia University of Science and Technology Baotou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Inner Mongolia

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7447

Reference24 articles.

1. Mast cell activation syndromes